Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03250338
Title Study Investigating the Efficacy of Crenolanib With Chemotherapy vs Chemotherapy Alone in R/R FLT3 Mutated AML
Recruitment Recruiting
Gender both
Phase Phase III
Variant Requirements Yes
Sponsors Arog Pharmaceuticals, Inc.
Indications

acute myeloid leukemia

Therapies

Cytarabine + Filgrastim + Fludarabine + Idarubicin + Mitoxantrone

Crenolanib + Cytarabine + Filgrastim + Fludarabine + Idarubicin + Mitoxantrone

Age Groups: senior | adult
Covered Countries USA | CAN

Additional content available in CKB BOOST